Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ubcare Co., Ltd. (032620:KRX), powered by AI.
Ubcare Co., Ltd. is currently trading at ₩3,155. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ubcare Co., Ltd. on Alpha Lenz.
Ubcare Co., Ltd.'s P/E ratio is 4.5.
“Ubcare Co., Ltd. trades at a P/E of 4.5 (undervalued) with strong ROE of 30.7%. 3Y revenue CAGR of 14.0% highlights clear growth momentum.”
Ask for details →Ubcare Co., Ltd. is a healthcare-focused company based in South Korea that primarily develops and supplies innovative medical software and equipment. Known for its expertise in creating electronic medical records (EMR) systems, Ubcare plays a crucial role in enhancing the efficiency and security of medical data management across healthcare facilities. The company's offerings extend to a range of digital solutions that support hospital information systems (HIS), aiming to improve patient care and streamline operations within hospitals and clinics. Ubcare's products also contribute to sectors such as telemedicine and digital healthcare, reflecting the company's commitment to integrating cutting-edge technology in traditional healthcare settings. In the financial market, Ubcare Co., Ltd. is recognized for its contribution to the expansion and digital transformation of healthcare infrastructure, making it a significant player in both the medical technology and broader health sectors.
“Ubcare Co., Ltd. trades at a P/E of 4.5 (undervalued) with strong ROE of 30.7%. 3Y revenue CAGR of 14.0% highlights clear growth momentum.”
Ask for details →Ubcare Co., Ltd. (ticker: 032620) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $164.7B.
The current price is ₩3,155 with a P/E ratio of 4.45x and P/B of 1.16x.
ROE is 30.72% and operating margin is 3.92%. Annual revenue is $197.7B.